Showing results (601-610 of 1,598) with videos related to
Sort By:
Pageof 160
Cancer Journal (Sudbury, Mass.)|June 25, 2016
BRAF-Directed Therapy in Metastatic Colorectal CancerKrittiya Korphaisarn, Scott KopetzCancer Journal (Sudbury, Mass.)|June 25, 2016
Immunotherapy Progress in Mismatch Repair-Deficient Colorectal Cancer and Future Therapeutic ChallengesJames T Link, Michael James OvermanCancer Journal (Sudbury, Mass.)|June 25, 2016
Vitamin D and Physical Activity in Patients With Colorectal Cancer: Epidemiological Evidence and Therapeutic ImplicationsVicente Morales-Oyarvide, Jeffrey A Meyerhardt, Kimmie NgCancer Journal (Sudbury, Mass.)|June 25, 2016
Value in Colorectal Cancer Treatment: Where It Is Lacking, and WhyLeonard B SaltzCancer Journal (Sudbury, Mass.)|September 22, 2015
Trastuzumab Emtansine (T-DM1) in Patients With HER2-Positive Metastatic Breast Cancer Previously Treated With Chemotherapy and 2 or More HER2-Targeted Agents: Results From the T-PAS Expanded Access StudyDenise A Yardley, Ian E Krop, Patricia M LoRusso, et al.Cancer Journal (Sudbury, Mass.)|September 22, 2015
Chemotherapy for Advanced-Stage Non-Small Cell Lung CancerLingling Du, Daniel MorgenszternCancer Journal (Sudbury, Mass.)|November 21, 2015
Special Review: Caught in the Crosshairs: Targeted Drugs and Personalized MedicineBibiana I Ferreira, Richard Hill, Wolfgang LinkCancer Journal (Sudbury, Mass.)|November 21, 2015
CD19-Targeted T Cells for Hematologic Malignancies: Clinical Experience to DateMarco L Davila, Craig Sauter, Renier BrentjensCancer Journal (Sudbury, Mass.)|December 1, 2017
Ablative Radiotherapy Doses for Locally Advanced: Pancreatic Cancer (LAPC)Christopher H Crane, Eileen M O'ReillyCancer Journal (Sudbury, Mass.)|January 24, 2018
Toxicities Associated With PD-1/PD-L1 BlockadeDaniel Y Wang, Douglas B Johnson, Elizabeth J DavisPageof 160